Summary

The North America nucleic acid isolation and purification market is expected to reach USD 7.65 billion by 2032 from USD 3.46 billion in 2024, growing at a CAGR of 11.0% in the forecast period of 2025 to 2032.
Market Segmentation:
North America Nucleic Acid Isolation and Purification Market, By Product (Instruments, Kits, and Reagents), Method (Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), Type (Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, and Others), Sample Type (FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, Brain and Kidney Tissue, and Others), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others), Country (U.S., Canada, and Mexico) - Industry Trends & Forecast To 2032
Overview of the North America Nucleic Acid Isolation and Purification Market Dynamics

Driver

• Increasing Prevalence Of Genetic Disorders

Restraint

• Risks Associated With Sample Contamination

Opportunity

• Rise In Technological Advancements and Automation

Market Players:

The key market players for North America nucleic acid isolation and purification market are listed below:

• Merck KGaA
• Cytiva (Danaher Corporation)
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Illumina Inc.
• PerkinElmer (now Revvity, Inc.)
• Meridian Bioscience, Inc.
• QIAGEN
• Takara Bio Inc.
• Promega Corporation
• New England Biolabs
• Omega Bio-tek, Inc.
• Zymo Research Corporation
• Analytik Jena GmbH+Co. KG
• LGC Biosearch Technologies

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 97
1.1 OBJECTIVES OF THE STUDY 97
1.2 MARKET DEFINITION 97
1.3 OVERVIEW OF NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 97
1.4 MARKETS COVERED 101
2 MARKET SEGMENTATION 105
2.1 MARKETS COVERED 105
2.2 GEOGRAPHICAL SCOPE 106
2.3 YEARS CONSIDERED FOR THE STUDY 107
2.4 CURRENCY AND PRICING 107
2.5 DBMR TRIPOD DATA VALIDATION MODEL 108
2.6 MULTIVARIATE MODELLING 111
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 112
2.8 DBMR MARKET POSITION GRID 113
2.9 VENDOR SHARE ANALYSIS 114
2.10 MARKET END USER COVERAGE GRID 115
2.11 SECONDARY SOURCES 116
2.12 ASSUMPTIONS 116
3 EXECUTIVE SUMMARY 117
4 PREMIUM INSIGHT 124
4.1 PORTER’S FIVE FORCES 125
4.2 PESTEL ANALYSIS 126
4.3 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR 127
5 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS 133
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION 133
5.2 NORTH AMERICA REGULATORY SCENARIO 138
5.3 EUROPE REGULATORY SCENARIO 143
5.4 REGULATORY SUBMISSIONS 145
6 MARKET OVERVIEW 156
6.1 DRIVERS 158
6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS 158
6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING 160
6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH 161
6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS 162
6.2 RESTRAINTS 163
6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION 163
6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS 164
6.3 OPPORTUNITIES 165
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION 165
6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS) 166
6.3.3 GROWING APPLICATIONS OF LIQUID BIOPSY IN NON-INVASIVE DIAGNOSTICS 167
6.4 CHALLENGES 169
6.4.1 TECHNICAL DIFFICULTIES IN NUCLEIC ACID ISOLATION ACROSS DIFFERENT SAMPLE TYPES 169
6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS 170
7 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 171
7.1 OVERVIEW 172
7.2 NEXT GENERATION SEQUENCING (NGS) 176
7.3 GENOMIC DNA ISOLATION AND PURIFICATION 176
7.4 TOTAL RNA ISOLATION AND PURIFICATION 177
7.5 PCR CLEAN-UP 177
7.6 PLASMID DNA ISOLATION AND PURIFICATION 178
7.7 MESSENGER RNA ISOLATION AND PURIFICATION 178
7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 179
7.9 MICRORNA ISOLATION AND PURIFICATION 179
7.10 OTHERS 180
8 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 181
8.1 OVERVIEW 182
8.2 INSTRUMENTS 185
8.2.1 HOMOGENIZER 186
8.2.2 SPECTROPHOTOMETERS 186
8.2.3 FLUOROMETERS 186
8.2.4 OTHERS 186
8.2.4.1 Benchtop 187
8.2.4.2 Standalone 187
8.2.4.2.1 Automated 187
8.2.4.2.2 Manual 187
8.3 KITS 187
8.3.1 DNA ISOLATION & PURIFICATION KITS 188
8.3.2 RNA ISOLATION & PURIFICATION KITS 188
8.3.3 VIRAL NUCLEIC ACID ISOLATION KITS 188
8.3.4 PLASMID PURIFICATION KIT 188
8.3.5 PCR AND GEL KIT 188
8.3.6 OTHERS 189
8.3.6.1 MAGNETIC BEAD-BASED KIT 189
8.3.6.2 COLUMN-BASED KIT 189
8.3.6.3 REAGENT-BASED KIT 189
8.3.6.3.1 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT 190
8.3.6.3.2 PLANT DNA ISOLATION KIT 190
8.3.6.3.3 CELL-FREE TOTAL NUCLEIC ACID KIT 190
8.3.6.3.4 CELL-FREE DNA ISOLATION KIT 190
8.3.7 GENOMIC DNA PURIFICATION KIT 192
8.3.8 VIRAL RNA/DNA PURIFICATION KIT 192
8.3.9 PLANT DNA PURIFICATION KIT 192
8.3.10 MICROBIOME DNA PURIFICATION KIT 192
8.3.11 OTHERS 192
8.3.12 MAGNETIC BEAD-BASED KIT 192
8.3.13 COLUMN-BASED KIT 192
8.3.14 REAGENT-BASED KIT 192
8.3.15 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT 194
8.3.16 MRNA PURIFICATION KIT 194
8.3.17 PLANT RNA ISOLATION KIT 194
8.3.18 CELL-FREE NUCLEIC ACID ISOLATION KIT 194
8.3.19 OTHERS 194
8.3.20 RNA ISOLATION KIT 195
8.3.21 MI RNA ISOLATION KIT 195
8.3.22 VIRAL RNA/DNA KIT 195
8.3.23 MAGNETIC BEAD-BASED KITS 196
8.3.24 VIRAL SPIN-COLUMN KITS 196
8.4 REAGENTS 196
8.4.1 DNA ISOLATION REAGENT 197
8.4.2 RNA ISOLATION REAGENT 197
8.4.3 OTHERS 197
9 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE 198
9.1 OVERVIEW 199
9.2 FFPE SAMPLES 202
9.3 BLOOD CELLS 202
9.4 BACTERIA, YEAST, AND PLANTS 203
9.5 CELL-FREE SAMPLES 203
9.6 CULTURED CELLS 204
9.7 MAMMALIAN CELLS 204
9.8 BRAIN AND KIDNEY TISSUE 205
9.9 OTHERS 205
10 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 206
10.1 OVERVIEW 207
10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 210
10.3 COLUMN -BASED ISOLATION AND PURIFICATION 210
10.4 REAGENT-BASED ISOLATION AND PURIFICATION 211
10.5 OTHERS 211
11 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 212
11.1 OVERVIEW 213
11.2 DIAGNOSTICS 216
11.2.1 INSTRUMENTS 216
11.2.2 KITS 216
11.2.3 REAGENTS 216
11.3 DRUG DISCOVERY AND DEVELOPMENT 217
11.3.1 INSTRUMENTS 217
11.3.2 KITS 217
11.3.3 REAGENTS 217
11.4 PERSONALIZED MEDICINE 218
11.4.1 INSTRUMENTS 218
11.4.2 KITS 218
11.4.3 REAGENTS 218
11.5 AGRICULTURE AND ANIMAL RESEARCH 219
11.5.1 INSTRUMENTS 219
11.5.2 KITS 219
11.5.3 REAGENTS 219
11.6 OTHERS 220
12 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 221
12.1 OVERVIEW 222
12.2 HOSPITALS AND DIAGNOSTIC CENTERS 225
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 225
12.4 CONTRACT RESEARCH ORGANIZATIONS 226
12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) 226
12.6 ACADEMIC/RESEARCH INSTITUTES 227
12.7 OTHERS 227
13 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 228
13.1 NORTH AMERICA 230
13.1.1 U.S. 247
13.1.2 CANADA 263
13.1.3 MEXICO 278
14 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE 293
14.1 COMPANY SHARE ANALYSIS: GLOBAL 293
15 SWOT ANALYSIS 294
16 COMPANY PROFILE 295
16.1 MERCK KGAA 295
16.1.1 COMPANY SNAPSHOT 295
16.1.2 REVENUE ANALYSIS 295
16.1.3 COMPANY SHARE ANALYSIS 296
16.1.4 PRODUCT PORTFOLIO 296
16.1.5 RECENT DEVELOPMENT 296
16.2 CYTIVA (DANAHER CORPORATION) 297
16.2.1 COMPANY SNAPSHOT 297
16.2.2 REVENUE ANALYSIS 297
16.2.3 COMPANY SHARE ANALYSIS 298
16.2.4 PRODUCT PORTFOLIO 298
16.2.5 RECENT DEVELOPMENTS 299
16.3 AGILENT TECHNOLOGIES, INC. 301
16.3.1 COMPANY SNAPSHOT 301
16.3.2 REVENUE ANALYSIS 301
16.3.3 COMPANY SHARE ANALYSIS 302
16.3.4 PRODUCT PORTFOLIO 302
16.3.5 RECENT DEVELOPMENT 305
16.4 BIO-RAD LABORATORIES, INC. 306
16.4.1 COMPANY SNAPSHOT 306
16.4.2 REVENUE ANALYSIS 306
16.4.3 COMPANY SHARE ANALYSIS 307
16.4.4 PRODUCT PORTFOLIO 307
16.4.5 RECENT DEVELOPMENT 308
16.5 F. HOFFMANN-LA ROCHE LTD 309
16.5.1 COMPANY SNAPSHOT 309
16.5.2 REVENUE ANALYSIS 309
16.5.3 COMPANY SHARE ANALYSIS 310
16.5.4 PRODUCT PORTFOLIO 310
16.5.5 RECENT DEVELOPMENT 310
16.6 ANALYTIK JENA GMBH+CO. KG 311
16.6.1 COMPANY SNAPSHOT 311
16.6.2 PRODUCT PORTFOLIO 311
16.6.3 RECENT DEVELOPMENT 311
16.7 AUTOGEN, INC. 313
16.7.1 COMPANY SNAPSHOT 313
16.7.2 PRODUCT PORTFOLIO 313
16.7.3 RECENT DEVELOPMENT 316
16.8 DAAN GENE CO., LTD. 317
16.8.1 COMPANY SNAPSHOT 317
16.8.2 PRODUCT PORTFOLIO 317
16.8.3 RECENT DEVELOPMENT 319
16.9 HIMEDIA LABORATORIES 320
16.9.1 COMPANY SNAPSHOT 320
16.9.2 PRODUCT PORTFOLIO 320
16.9.3 RECENT DEVELOPMENT 321
16.10 ILLUMINA, INC. 322
16.10.1 COMPANY SNAPSHOT 322
16.10.2 REVENUE ANALYSIS 322
16.10.3 PRODUCT PORTFOLIO 323
16.10.4 RECENT DEVELOPMENT 323
16.11 KURABO INDUSTRIES LTD. 324
16.11.1 COMPANY SNAPSHOT 324
16.11.2 REVENUE ANALYSIS 324
16.11.3 PRODUCT PORTFOLIO 325
16.11.4 RECENT DEVELOPMENT 327
16.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 328
16.12.1 COMPANY SNAPSHOT 328
16.12.2 REVENUE ANALYSIS 328
16.12.3 PRODUCT PORTFOLIO 329
16.12.4 RECENT DEVELOPMENT 330
16.13 LGC BIOSEARCH TECHNOLOGIES 331
16.13.1 COMPANY SNAPSHOT 331
16.13.2 PRODUCT PORTFOLIO 331
16.13.3 RECENT DEVELOPMENTS 332
16.14 MACHEREY-NAGEL GMBH & CO. KG 333
16.14.1 COMPANY SNAPSHOT 333
16.14.2 PRODUCT PORTFOLIO 333
16.14.3 RECENT DEVELOPMENT 333
16.15 MAGGENOME TECHNOLOGIES PVT. LTD. 334
16.15.1 COMPANY SNAPSHOT 334
16.15.2 PRODUCT PORTFOLIO 334
16.15.3 RECENT DEVELOPMENT 338
16.16 MEDOX BIOTECH INDIA PVT. LTD. 339
16.16.1 COMPANY SNAPSHOT 339
16.16.2 PRODUCT PORTFOLIO 339
16.16.3 RECENT DEVELOPMENT 340
16.17 MERIDIAN BIOSCIENCE, INC. 341
16.17.1 COMPANY SNAPSHOT 341
16.17.2 PRODUCT PORTFOLIO 341
16.17.3 RECENT DEVELOPMENT 341
16.18 NEW ENGLAND BIOLABS 342
16.18.1 COMPANY SNAPSHOT 342
16.18.2 PRODUCT PORTFOLIO 342
16.18.3 RECENT DEVELOPMENT 343
16.19 NORGEN BIOTEK CORP. 344
16.19.1 COMPANY SNAPSHOT 344
16.19.2 PRODUCT PORTFOLIO 344
16.19.3 RECENT DEVELOPMENT 345
16.20 OMEGA BIO-TEK, INC. 346
16.20.1 COMPANY SNAPSHOT 346
16.20.2 PRODUCT PORTFOLIO 346
16.20.3 RECENT DEVELOPMENT 348
16.21 PCR BIOSYSTEMS 349
16.21.1 COMPANY SNAPSHOT 349
16.21.2 PRODUCT PORTFOLIO 349
16.21.3 RECENT DEVELOPMENT 349
16.22 PERKINELMER 350
16.22.1 COMPANY SNAPSHOT 350
16.22.2 REVENUE ANALYSIS 350
16.22.3 PRODUCT PORTFOLIO 351
16.22.4 RECENT DEVELOPMENT 351
16.23 PROMEGA CORPORATION 352
16.23.1 COMPANY SNAPSHOT 352
16.23.2 PRODUCT PORTFOLIO 352
16.23.3 RECENT DEVELOPMENT 352
16.24 QIAGEN 353
16.24.1 COMPANY SNAPSHOT 353
16.24.2 REVENUE ANALYSIS 353
16.24.3 PRODUCT PORTFOLIO 354
16.24.4 RECENT DEVELOPMENTS/NEWS 355
16.25 SAGE SCIENCE, INC. 356
16.25.1 COMPANY SNAPSHOT 356
16.25.2 PRODUCT PORTFOLIO 356
16.25.3 RECENT DEVELOPMENTS 356
16.26 TAKARA BIO INC. 358
16.26.1 COMPANY SNAPSHOT 358
16.26.2 REVENUE ANALYSIS 358
16.26.3 PRODUCT PORTFOLIO 359
16.26.4 RECENT DEVELOPMENTS 359
16.27 THERMO FISHER SCIENTIFIC INC. 360
16.27.1 COMPANY SNAPSHOT 360
16.27.2 REVENUE ANALYSIS 360
16.27.3 PRODUCT PORTFOLIO 361
16.27.4 RECENT DEVELOPMENT 364
16.28 TIANGEN BIOTECH (BEIJING) CO.,LTD. 366
16.28.1 COMPANY SNAPSHOT 366
16.28.2 PRODUCT PORTFOLIO 366
16.28.3 RECENT DEVELOPMENT 366
16.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD 367
16.29.1 COMPANY SNAPSHOT 367
16.29.2 PRODUCT PORTFOLIO 367
16.29.3 RECENT DEVELOPMENT 368
16.30 ZYMO RESEARCH CORPORATION 369
16.30.1 COMPANY SNAPSHOT 369
16.30.2 PRODUCT PORTFOLIO 369
16.30.3 RECENT DEVELOPMENT 370
17 QUESTIONNAIRE 371
18 RELATED REPORTS 375